GRAL logo

GRAIL (GRAL) EBITDA

Annual EBITDA

-$638.22 M
-$50.52 M-8.60%

December 31, 2023

Summary

Performance

1-Year Change

-8.6%

3-Year Change

-8.6%

5-Year Change

-133.42%

15-Year Change

-133.42%

GRAL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.8%
GRAL annual EBITDA is higher than 0.8% of companies in Healthcare sector

High & Low

All-time High

-$245.36 M

3-Year Low

-$638.22 M
GRAL annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GRAL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
GRAL next annual earnings announcement is scheduled for Feb 28, 2025

OtherGRALprofitabilitymetrics:

Annual Revenue

$93.11 M
GRAL annual revenue is $93.11 million

Annual Net Income

-$1.28 B
GRAL annual net profit is -$1.28 billion

Annual EBIT

-$796.92 M
GRAL annual earnings before interest & taxes is -$796.92 million

Annual EPS

-$41.34
GRAL annual earnings per share is -$41.34

Quarterly EBITDA

-$144.28 M
+$36.69 M+20.27%

September 1, 2024

Summary

Performance

3-Month Change

+20.27%

1-Year Change

+6.39%

3-Year Change

+12.69%

5-Year Change

-

GRAL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.27%
GRAL quarterly EBITDA is higher than 1.27% of companies in Healthcare sector

High & Low

All-time High

-$144.28 M
GRAL quarterly EBITDA is currently at an all-time high

3-Year Low

-$188.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GRAL previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
GRAL next earnings announcement is scheduled for Feb 28, 2025

OtherGRALprofitabilitymetrics:

Quarterly Revenue

$28.65 M
GRAL quarterly revenue is $28.65 million

Quarterly Net Income

-$125.69 M
GRAL quarterly net profit is -$125.69 million

Quarterly EBIT

-$183.51 M
GRAL quarterly earnings before interest & taxes is -$183.51 million

Quarterly EPS

-$3.94
GRAL quarterly earnings per share is -$3.94

TTM EBITDA

-$668.18 M
+$9.85 M+1.45%

September 1, 2024

Summary

Performance

3-Month Change

+1.45%

1-Year Change

-38.18%

3-Year Change

-102.83%

5-Year Change

-

GRAL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.02%
GRAL TTM EBITDA is higher than 1.02% of companies in Healthcare sector

High & Low

All-time High

-$164.19 M

3-Year Low

-$678.03 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GRAL previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
GRAL next earnings announcement is scheduled for Feb 28, 2025

OtherGRALprofitabilitymetrics:

TTM Revenue

$117.67 M
GRAL TTM revenue is $117.67 million

TTM Net Income

-$1.88 B
GRAL TTM net profit is -$1.88 billion

TTM EBIT

-$826.72 M
GRAL TTM earnings before interest & taxes is -$826.72 million

TTM EPS

-$60.54
GRAL TTM earnings per share is -$60.54

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$638.22 M
GRAL annual EBITDA is -$638.22 million

Annual Net Income

-$1.28 B
GRAL annual net profit is -$1.28 billion

Annual Interest Expense

-
GRAL annual interest expense value is unknown

Annual Income Tax

-$223.98 M
GRAL annual income tax is -$223.98 million

Annual D&A

$158.70 M
GRAL annual depreciation & amortization is $158.70 million

GRAL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.6%+6.4%-38.2%
3 y3 years-8.6%+12.7%-102.8%
5 y5 years-133.4%--

GRAL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-160.1%at lowat high+23.4%-306.9%+1.4%
5 y5-year-160.1%at lowat high+23.4%-306.9%+1.4%
alltimeall time-160.1%at lowat high+23.4%-306.9%+1.4%

GRAIL EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$144.28 M(-20.3%)
-$668.18 M(-1.5%)
Jun 2024
-
-$180.97 M(-3.9%)
-$678.03 M(+2.4%)
Mar 2024
-
-$188.27 M(+21.7%)
-$662.30 M(+3.8%)
Dec 2023
-$638.22 M
-
-
Dec 2023
-
-$154.66 M(+0.3%)
-$638.22 M(+32.0%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$154.13 M(-6.7%)
-$483.56 M(+46.8%)
Jun 2023
-
-$165.24 M(+0.6%)
-$329.43 M(+100.6%)
Mar 2023
-
-$164.19 M
-$164.19 M
Dec 2022
-$587.70 M(+139.5%)
-
-
Dec 2019
-$245.36 M(-10.3%)
-
-
Dec 2018
-$273.42 M
-
-

FAQ

  • What is GRAIL annual EBITDA?
  • What is the all time high annual EBITDA for GRAIL?
  • What is GRAIL annual EBITDA year-on-year change?
  • What is GRAIL quarterly EBITDA?
  • What is the all time high quarterly EBITDA for GRAIL?
  • What is GRAIL quarterly EBITDA year-on-year change?
  • What is GRAIL TTM EBITDA?
  • What is the all time high TTM EBITDA for GRAIL?
  • What is GRAIL TTM EBITDA year-on-year change?

What is GRAIL annual EBITDA?

The current annual EBITDA of GRAL is -$638.22 M

What is the all time high annual EBITDA for GRAIL?

GRAIL all-time high annual EBITDA is -$245.36 M

What is GRAIL annual EBITDA year-on-year change?

Over the past year, GRAL annual EBITDA has changed by -$50.52 M (-8.60%)

What is GRAIL quarterly EBITDA?

The current quarterly EBITDA of GRAL is -$144.28 M

What is the all time high quarterly EBITDA for GRAIL?

GRAIL all-time high quarterly EBITDA is -$144.28 M

What is GRAIL quarterly EBITDA year-on-year change?

Over the past year, GRAL quarterly EBITDA has changed by +$9.85 M (+6.39%)

What is GRAIL TTM EBITDA?

The current TTM EBITDA of GRAL is -$668.18 M

What is the all time high TTM EBITDA for GRAIL?

GRAIL all-time high TTM EBITDA is -$164.19 M

What is GRAIL TTM EBITDA year-on-year change?

Over the past year, GRAL TTM EBITDA has changed by -$184.62 M (-38.18%)